Technomark is an investment group with a life science focus.
Since 1987, Technomark has had an impeccable reputation in the life science industry for strategic outsourcing, venture capital, and product development.
Today, our global presence allows us to make a difference by providing turn-key solutions for preclinical and clinical development in the US, UK and the rest of Europe, and India, as part of our co-development business model.
As long-term investors we co-fund the product development of our portfolio companies in a hands-on manner. |
|
| |
| Investment Summary |
| Industry sector: |
|
Therapeutics, biotech, start-up, med device/diagnostic, med-tech, small/specialty pharma |
| Size of investment: |
|
30-70% cost of the development studies |
| Investment stage: |
|
Preclinical, IND-enabling, tox, Phase I-III |
| Return on investment: |
|
Equity, downstream royalties, milestone payments, etc. |
| Geography: |
|
Primarily US, UK and rest of EU, Israel |
|
